Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated traditional Chinese and Western medicine for ankylosing spondylitis
ChiCTR-TRC-11001274Phase 4Completed
- Sponsor
- Southern Medical University
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qiangji, 5-aminosalicylic acid + sulphasalazine and ibuprofen in ankylosing spondylitis (AS) (2 arms), sponsored by Southern Medical University. Primary endpoints: Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Quality of Life and 6 more. Started Apr 2011; status: completed.
02
Drugs
Qiangji5-aminosalicylic acid + sulphasalazineibuprofen
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on ChiCTR-TRC-11001274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001274.